PRLB Stock Cash Flow Statements

Proto Labs Quarterly Cash Flow Statements Chart

Quarterly

Annual

Stock-Based Compensation

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Capital Expenditure

Proto Labs Quarterly Cash Flow Statements Table

Quarterly

Annual

Unit: USD	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30	2020-03-31	2019-12-31	2019-09-30	2019-06-30	2019-03-31	2018-12-31	2018-09-30	2018-06-30	2018-03-31	2016-06-30	2016-03-31	2015-03-31	2013-09-30	2013-06-30	2013-03-31	2012-12-31	2012-09-30	2012-06-30	2012-03-31

operating activities
net income	4,427,000	3,599,000	-404,000	7,189,000	4,540,000	5,268,000	6,990,000	7,954,000	-383,000	2,659,000	-115,065,000	3,951,000	2,557,000	5,095,000	11,910,000	4,835,000	12,915,000	3,712,000	9,579,000	14,697,000	12,607,000	13,984,000	15,186,000	16,792,000	16,166,000	15,511,000	19,286,000	20,937,000	18,314,000	18,051,000	10,691,000	10,662,000	10,453,000	8,872,000	8,611,000	8,287,000	7,395,000	6,702,000	5,146,000	4,782,000
adjustments to reconcile net income to net cash from operating activities:
depreciation and amortization	8,570,000	8,694,000	8,824,000	8,909,000	8,972,000	9,103,000	9,315,000	9,330,000	9,495,000	9,388,000	9,444,000	9,707,000	10,042,000	10,232,000	10,257,000	10,104,000	10,068,000	10,059,000	8,703,000	8,036,000	7,897,000	7,958,000	8,206,000	7,677,000	7,542,000	7,439,000	7,234,000	6,771,000	6,490,000	6,259,000	4,358,000	3,789,000	3,399,000	1,946,000	1,848,000	1,734,000	1,700,000	1,612,000	1,440,000	1,328,000
stock-based compensation expense	4,259,000	3,992,000	4,283,000	4,196,000	4,244,000	4,276,000	4,178,000	4,441,000	3,675,000	3,695,000	4,210,000	4,907,000	4,031,000	4,397,000	3,556,000	4,978,000	4,941,000	5,620,000	4,056,000	3,945,000	3,639,000	3,033,000	1,043,000	3,212,000	3,486,000	3,040,000	2,942,000	2,952,000	2,727,000	2,307,000	1,809,000	1,732,000	1,342,000	859,000	871,000	865,000	677,000	742,000	770,000	850,000
deferred taxes	-2,433,000	-1,552,000	987,000	-1,996,000	-1,897,000	-2,247,000	1,541,000	-3,592,000	-2,509,000	-3,096,000	-579,000	-3,267,000	-2,440,000	-3,213,000	478,000	-558,000	488,000	-69,000	999,000	927,000	2,259,000	3,392,000	4,507,000	14,000	1,206,000	379,000	10,166,000	150,000	1,008,000	612,000	314,000	89,000	343,000	-368,000	159,000	148,000
interest on finance lease obligations	5,000	6,000	7,000	8,000	8,000	10,000	196,000	291,000	281,000	287,000
impairments related to exit and closure of facilities	229,000	219,000
gain on disposal of property and equipment			11,000	-4,000	2,000	-22,000	0	-70,000			-37,000
other	-125,000	43,000	-102,000	39,000	1,000	63,000	32,000	-93,000	261,000	-46,000	24,000	-21,000	-47,000	79,000	135,000	15,000	-30,000	155,000	529,000	-11,000	-210,000	-644,000	524,000	146,000	-515,000	236,000	-779,000	153,000	-99,000	106,000
changes in operating assets and liabilities:
accounts receivable	-2,082,000	-7,405,000	5,069,000	4,468,000	5,767,000	-5,654,000	5,785,000	-4,164,000	3,434,000	-2,328,000	5,541,000	1,839,000	581,000	-6,329,000	5,503,000	-2,319,000	-8,738,000	-14,558,000	3,721,000	480,000	792,000	-5,084,000	7,235,000	-1,926,000	-1,075,000	-2,386,000	2,895,000	-6,345,000	1,365,000	-4,013,000	1,178,000	23,000	-4,363,000	-210,000	-103,000	-1,929,000	-595,000	-1,509,000	940,000	-3,208,000
inventories	-285,000	-698,000	-63,000	58,000	461,000	802,000	262,000	401,000	90,000	-641,000	1,303,000	170,000	-1,108,000	-675,000	-3,340,000	-777,000	810,000	917,000	-346,000	485,000	-264,000	-537,000	-491,000	159,000	-347,000	739,000	-513,000	-65,000	-418,000	807,000	-125,000	-62,000	-243,000	-20,000	-177,000	-183,000	-316,000	-324,000	-62,000	-127,000
prepaid expenses and other	-179,000	517,000	-248,000	517,000	-470,000	-359,000	76,000	-66,000	2,729,000	1,464,000	-1,161,000	-622,000	-1,408,000	1,110,000	-945,000	-801,000	-886,000	2,696,000	-672,000	60,000	172,000	-1,240,000	707,000	-186,000	235,000	-211,000	-40,000	-999,000	648,000	-1,707,000	411,000	-1,557,000	-989,000	-170,000	1,322,000	393,000	-1,631,000	-283,000	-2,000	29,000
income taxes	-1,866,000	3,702,000	-3,274,000	1,758,000	-4,632,000	5,457,000	-2,870,000	1,169,000	-1,636,000	5,160,000	-3,351,000	1,920,000	-5,769,000	4,519,000	452,000	2,789,000	-3,832,000	-183,000	-635,000	16,000	-500,000	-841,000	-2,610,000	4,332,000	1,827,000	3,006,000	-8,930,000	2,145,000	-2,254,000	2,387,000	688,000	5,296,000	2,729,000	3,033,000	347,000	2,719,000	1,964,000	1,690,000	-1,331,000	1,991,000
accounts payable	-1,412,000	758,000	3,189,000	-3,246,000	675,000	-138,000	-2,584,000	1,707,000	-3,497,000	2,536,000	83,000	1,813,000	-195,000	-326,000	2,676,000	-3,033,000	4,342,000	669,000	2,749,000	-2,339,000	-657,000	1,739,000	-2,198,000	-2,369,000	4,653,000	-805,000	962,000	-3,428,000	2,117,000	2,291,000	-1,233,000	-135,000	776,000	481,000	-32,000	1,115,000	618,000	51,000	-1,707,000	1,344,000
accrued liabilities and other	1,476,000	6,504,000	-3,318,000	2,602,000	-3,228,000	4,779,000	-5,693,000	6,871,000	-6,129,000	3,500,000	-7,905,000	251,000	5,221,000	2,894,000	-3,190,000	-3,145,000	1,816,000	-2,564,000	-4,302,000	2,589,000	5,198,000	595,000	154,000	1,052,000	3,717,000	-8,962,000	4,706,000	3,314,000	3,832,000	-1,118,000	2,472,000	-1,872,000	2,175,000	2,872,000	-3,069,000	1,759,000	245,000	1,737,000	-1,072,000	367,000
net cash from operating activities	10,584,000	18,379,000	17,294,000	24,754,000	14,443,000	21,338,000	17,228,000	24,179,000	9,289,000	22,578,000	10,515,000	20,524,000	13,257,000	17,783,000	23,017,000	11,496,000	14,304,000	6,425,000	24,594,000	28,958,000	31,007,000	22,410,000	32,273,000	28,891,000	36,886,000	18,002,000	37,967,000	25,645,000	33,172,000	26,145,000	19,618,000	16,944,000	15,417,000	15,452,000	8,303,000	11,145,000	6,045,000	7,783,000	4,067,000	7,411,000
capex	-1,468,000	-1,262,000	-830,000	-1,555,000	-4,197,000	-2,587,000	-18,181,000	-3,106,000	-3,388,000	-3,441,000	-5,272,000	-10,384,000	-2,961,000	-3,069,000	-6,253,000	-4,027,000	-17,383,000	-6,546,000	-6,521,000	-7,184,000	-19,884,000	-13,421,000	-16,079,000	-12,015,000	-21,401,000	-12,735,000	-25,206,000	0	-17,681,000	-25,513,000	-14,141,000	-8,275,000	-6,230,000	-6,907,000	-3,521,000	-2,548,000	-2,962,000	-1,771,000	-4,400,000	-8,264,000
free cash flows	9,116,000	17,117,000	16,464,000	23,199,000	10,246,000	18,751,000	-953,000	21,073,000	5,901,000	19,137,000	5,243,000	10,140,000	10,296,000	14,714,000	16,764,000	7,469,000	-3,079,000	-121,000	18,073,000	21,774,000	11,123,000	8,989,000	16,194,000	16,876,000	15,485,000	5,267,000	12,761,000	25,645,000	15,491,000	632,000	5,477,000	8,669,000	9,187,000	8,545,000	4,782,000	8,597,000	3,083,000	6,012,000	-333,000	-853,000
investing activities
purchases of property, equipment and other capital assets	-1,468,000	-1,262,000	-830,000	-1,555,000	-4,197,000	-2,587,000	-18,181,000	-3,106,000	-3,388,000	-3,441,000	-5,272,000	-10,384,000	-2,961,000	-3,069,000	-6,253,000	-4,027,000	-17,383,000	-6,546,000	-6,521,000	-7,184,000	-19,884,000	-13,421,000	-16,079,000	-12,015,000	-21,401,000	-12,735,000	-25,206,000
proceeds from sales of property, equipment and other capital assets			0	4,000	8,000	22,000	6,000	70,000	429,000	194,000	881,000
purchases of marketable securities	-4,500,000	-6,552,000	-6,983,000								-1,000,000	-6,990,000	-9,516,000	-29,366,000	-1,000,000	0	-6,932,000	-8,227,000	-22,604,000	-33,384,000	-19,583,000	-37,629,000	-28,960,000	-8,460,000			0	-24,255,000	-13,740,000	-3,389,000	-19,510,000	-18,794,000	-11,575,000	-25,347,000	-16,222,000	-41,088,000	-22,824,000	-27,053,000
proceeds from call redemptions and maturities of marketable securities	5,325,000	4,905,000		5,290,000	3,435,000	6,984,000		5,095,000	6,390,000	7,630,000		6,300,000	796,000	6,600,000
net cash from investing activities	-643,000	-2,909,000	-2,897,000	-14,348,000	-754,000	4,419,000	-14,425,000	2,059,000	3,431,000	4,383,000	273,000	-6,849,000	-10,681,000	-25,835,000	3,661,000	6,757,000	-14,949,000	-90,133,000	-17,816,000	-12,365,000	-21,942,000	-43,350,000	-31,061,000	4,707,000	-18,220,000	271,000	-4,788,000	-27,420,000	-15,632,000	-15,441,000	-15,357,000	-16,604,000	-6,159,000	-15,871,000	-3,776,000	-25,323,000	-13,708,000	-18,784,000	-38,742,000	-8,014,000
financing activities
proceeds from issuance of common stock from equity plans	1,794,000	287,000
purchases of shares withheld for tax obligations	-1,869,000	-1,248,000	-75,000	0	-1,387,000	-533,000	0	-11,000	-1,024,000	-401,000	-67,000	0	-1,147,000	-468,000	-16,000	0	-2,215,000	-1,994,000	-76,000	0	-2,319,000	-1,048,000	-67,000	-2,000	-1,824,000	-594,000
repurchases of common stock	-3,090,000	-20,890,000		-19,018,000	-10,927,000	-16,013,000		-8,989,000	-8,945,000	-21,119,000	-16,585,000	-7,835,000			-10,243,000	-11,826,000			0	0	-3,501,000	-11,185,000	0	-12,111,000	-4,101,000	-17,309,000
principal repayments of finance lease obligations	-77,000	-76,000	-76,000	-74,000	-73,000	-73,000	-72,000	-71,000	-81,000	-82,000	-114,000	-139,000	-139,000	-139,000	-139,000	-138,000	-138,000	-137,000
net cash from financing activities	-3,242,000	-21,927,000	-12,546,000	-19,092,000	-10,293,000	-16,619,000	-3,121,000	-9,071,000	-8,064,000	-21,602,000	-15,127,000	-7,974,000	-4,220,000	-601,000	-8,378,000	-11,964,000	-1,429,000	-427,000	1,653,000	2,819,000	-3,100,000	-12,098,000	1,838,000	-11,870,000	-3,856,000	-17,729,000	-10,686,000	1,942,000	1,054,000	-2,748,000	2,721,000	2,524,000	339,000	3,989,000	3,039,000	5,594,000	8,182,000	3,228,000	-235,000	71,611,000
effect of exchange rate changes on cash and cash equivalents	991,000	78,000	-653,000	410,000	-51,000	-124,000	612,000	-164,000	-214,000	134,000	1,536,000	-1,006,000	-929,000	-37,000	-173,000	-396,000	209,000	306,000	918,000	839,000	133,000	-282,000	607,000	-695,000	375,000	-240,000	-40,000	-179,000	-1,084,000	432,000	-277,000	109,000	-373,000	366,000	-49,000	-246,000	-50,000	-323,000
net increase in cash and cash equivalents	7,690,000	-6,379,000	1,198,000	-8,276,000	3,345,000	9,014,000	294,000	17,003,000	4,442,000	5,493,000									9,349,000	20,251,000	6,098,000	-33,320,000	3,657,000	21,033,000	15,185,000	304,000	22,453,000	-12,000	17,510,000	8,388,000	6,705,000	2,973,000	9,224,000	3,936,000	7,517,000	-8,830,000	469,000	-8,096,000
cash and cash equivalents, beginning of period	0	89,071,000	0	0	0	83,790,000	0	0	0	56,558,000	0	0	0	65,929,000	0	0	0	127,603,000	0	0	0	125,225,000	0	0	0	85,046,000	0	0	0	36,707,000	0	47,653,000	43,329,000	0	0	36,759,000	0	0
cash and cash equivalents, end of period	7,690,000	82,692,000	1,198,000	-8,276,000	3,345,000	92,804,000	294,000	17,003,000	4,442,000	62,051,000	-2,803,000	4,695,000	-2,573,000	57,239,000	18,127,000	5,893,000	-1,865,000	43,774,000	9,349,000	20,251,000	6,098,000	91,905,000	3,657,000	21,033,000	15,185,000	85,350,000	22,453,000	-12,000	17,510,000	45,095,000	6,705,000	50,626,000	52,553,000	3,936,000	7,517,000	27,929,000	469,000	-8,096,000
loss on impairment of goodwill
loss on foreign currency translation							0	0
loss on impairment of equipment			0
impairments related to exit and closure of germany and japan businesses
changes in operating assets and liabilities, net of acquisitions:
purchases of other assets and investments																			0	0	0	-3,000,000	0	0	0	-4,000,000	0
proceeds from sales of marketable securities											0	998,000			7,824,000	9,395,000	2,500,000	45,194,000
proceeds from maturities of marketable securities															3,090,000	1,389,000	6,570,000	7,155,000	11,309,000	28,203,000	17,525,000	10,700,000	13,978,000	25,182,000	12,164,000	17,006,000	20,418,000	15,665,000	15,505,000	13,551,000				16,383,000	15,967,000	18,313,000
repurchases of common stock and other
supplemental cash flow disclosure
cash paid for interest
cash paid for taxes
proceeds from exercises of stock options and employee stock purchases
proceeds from exercises of stock options								0				0	2,305,000	6,000	2,024,000	0	2,134,000	1,704,000	1,883,000	2,819,000	2,720,000	135,000	1,905,000	243,000	2,069,000	174,000
changes in fair value of contingent consideration
impairments related to closure of japan business											0	1,050,000
cash from acquisitions, net of cash acquired															0	0	296,000	-127,709,000									0	0	0	-90,000
fair value of contingent consideration																-750,000
net decrease in cash and cash equivalents												4,695,000	-2,573,000	-8,690,000		5,893,000	-1,865,000	-83,829,000
amortization of marketable securities																113,000	124,000	137,000
realized loss on available-sale-securities
realized gain on available-sale-securities																45,000	49,000	-166,000
gain on sale of businesses
amortization of held-to-maturity securities																			213,000	73,000	74,000	55,000	10,000	-12,000	-9,000	16,000	38,000	60,000	113,000	163,000	301,000	289,000	305,000	374,000	329,000	304,000
proceeds from sale of businesses
payments on debt																											0	0	0	-5,000,000			-49,000	-45,000	-74,000	-92,000	-99,000	-98,000	-97,000	-94,000
loss on impairment of assets
proceeds from issuance of debt
proceeds from sale of business																											0
gain on sale of business																											0
acquisition-related contingent consideration																															0	-400,000	-1,000,000
proceeds from exercises of stock options and other																											1,543,000	1,942,000	1,054,000	2,252,000	2,115,000	1,614,000	878,000
purchases of property and equipment																													-17,681,000	-25,513,000	-14,141,000	-8,275,000	-6,230,000	-6,907,000	-3,521,000	-2,548,000	-2,962,000	-1,771,000	-4,400,000	-8,264,000
repurchase of common stock
gain on acquisition
excess tax benefit from stock-based compensation																															-606,000	-1,310,000	-510,000	-2,269,000	-1,862,000	-4,067,000	-3,583,000
proceeds from sales and maturities of marketable securities																																10,465,000	11,646,000
loss on disposal of property and equipment																																		52,000						5,000
proceeds from initial public offering, net of offering costs																																					0	0	-145,000	71,675,000
proceeds from exercises of warrants and stock options																																		1,765,000	1,251,000	1,619,000	2,247,000	691,000	7,000	30,000
loss on impairment of foreign subsidiary assets
proceeds from sale of property and equipment
proceeds from follow-on offering, net of offering costs
proceeds from sale of marketable securities																																						10,040,000	0	250,000
benefit from doubtful accounts																																								23,000
benefit from excess inventory																																								27,000
effect of exchange rate changes on cash																																								536,000
net increase in cash																																								71,544,000
cash, beginning of period																																								8,135,000
cash, end of period																																								79,679,000
less: dividends on redeemable convertible preferred stock
less: undistributed earnings allocated to preferred shareholders
net income attributable to common shareholders																																								4,782,000
basic—weighted-average shares outstanding:																																								20,934,948,000
effect of dilutive securities:
employee stock options and warrants																																								1,248,737,000
employee stock purchase plan																																								42,671,000
diluted—weighted-average shares outstanding:																																								22,226,356,000
net income per share
basic																																								230
diluted																																								220

We provide you with 20 years of cash flow statements for Proto Labs stock, allowing you to gain comprehensive visibility into the fundamentals of the company. Our detailed breakdowns include key financial metrics such as operating cash flows, cash levels, capital expenditures, profits, stock-based compensations and profit margins. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of Proto Labs stock. Explore the full financial landscape of Proto Labs stock with our expertly curated income statements.

The information provided in this report about Proto Labs stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.